MCS therapy for AMD

Still in off-label use, the micro-stimulation (MCS) therapy is thought to improve eye health by increasing the blood flow to the eyes. MCS therapy uses a small battery-operated device to deliver low-intensity electricity to points around the eyes. In this way, more oxygen is allowed to get into the tissues. In addition, MCS therapy can help remove waste products and stimulate retinal cells that have become dormant and sluggish.

Until now, MCS therapy has only undergone a two-year preliminary trial involving 120 participants. Being considered to treat the retinal disease, MCS therapy using a special device is still practiced in off-label. But there are many positive signs of the therapy. Until now, there are no side effects associated with this noninvasive and painless therapy. Among participants of the trial, no cases show an increase in the conversion to the wet form of age related macular degeneration. According to the NIH reports, “one of the advantages...is that the incidence of adverse affects is substantially lower than that of many drugs or other accepted medical procedures used for the same conditions”.

It seems that MCS only lacks an official approval from the Food and Drug Administration (FDA), who regulates the sale of medical devices. In fact, all medical devices should receive FDA approval before being available to the public. This is the basic rule all medical companies should obey. Originally used to relieve chronic, untreatable pain, the devices now used in MCS therapy must present enough evidence that they are reasonably safe and effective. Only with an approval from the FDA, MCS device can be chosen by doctors in the best interest of their patients.

If you want to know more about vision knowledge, then feel free to visit https://vision.firmoo.com/eye-diseases

you will get some help about eye care clinics and eye doctors in following optical eyeglasses stores of Waldo:Sara Sconzert